Vertex (VRTX) delivered earnings and revenue surprises of 6.52% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
BOSTON, February 07, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2022 and provided full year 2023 financial guidance.
It's even possible that we could soon see the beginning of a new bull market. Investors could have the equivalent of this happen with the stock market. If the stock market indeed retreats, one of the most likely culprits is that investors fear a recession is coming.